|
TNPO2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.751800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.831800E-02 |
| Normal-vs-Stage2 |
6.930400E-01 |
| Normal-vs-Stage3 |
2.728300E-02 |
| Normal-vs-Stage4 |
3.847800E-01 |
| Stage1-vs-Stage2 |
1.129960E-01 |
| Stage1-vs-Stage3 |
7.436200E-01 |
| Stage1-vs-Stage4 |
3.004800E-01 |
| Stage2-vs-Stage3 |
1.030560E-01 |
| Stage2-vs-Stage4 |
6.627800E-01 |
| Stage3-vs-Stage4 |
2.560000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.322500E-02 |
| Normal-vs-AfricanAmerican |
5.916400E-01 |
| Normal-vs-Asian |
8.565700E-02 |
| Caucasian-vs-AfricanAmerican |
3.853700E-02 |
| Caucasian-vs-Asian |
9.233000E-01 |
| AfricanAmerican-vs-Asian |
6.596100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.553200E-01 |
| Normal-vs-Female |
2.596000E-02 |
| Male-vs-Female |
1.969580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.235800E-02 |
| Normal-vs-Age(41-60Yrs) |
5.242500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.131800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.878960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.708800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.310800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.958400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.130600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.122400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.849000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.014020E-01 |
| Classical-VS-Follicular |
9.645400E-01 |
| Classical-VS-Other |
9.467200E-01 |
| Classical-VS-Normal |
1.353970E-01 |
| Tall-VS-Follicular |
1.432770E-01 |
| Tall-VS-Other |
3.573200E-01 |
| Tall-VS-Normal |
1.075720E-02 |
| Follicular-VS-Other |
9.384600E-01 |
| Follicular-VS-Normal |
1.893570E-01 |
| Other-VS-Normal |
5.883000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.763640E-01 |
| Normal-vs-N1 |
7.722000E-02 |
| N0-vs-N1 |
4.019800E-01 |
|
|
